- Home
- MGX
MGX
METAGENOMI INC
as 07-26-2024 4:00pm EST
Stocks
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | 192.6M | IPO Year: | 2024 |
| Target Price: | $17.83 | AVG Volume (30 days): | 96.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.34 - $12.74 | Next Earning Date: | 08-12-2024 |
| Revenue: | $47,258,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | -11.4% | Revenue Growth (next year): | -32.88% |
Stock Insider Trading Activity of METAGENOMI INC (MGX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Novo Holdings A/S | MGX | 10% Owner | Feb 9 '24 | Buy | $10.25 | 100,000 | $1,025,000.00 | 100,000 | SEC Form 4 |
| Novo Holdings A/S | MGX | 10% Owner | Feb 9 '24 | Buy | $15.00 | 800,000 | $12,000,000.00 | 1,739,175 | SEC Form 4 |
Latest METAGENOMI INC News
MGX Breaking Stock News: Dive into MGX Ticker-Specific Updates for Smart Investing
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Simply Wall St.
2 months ago
Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
Simply Wall St.
2 months ago
American Software Full Year 2024 Earnings: EPS Beats Expectations
Simply Wall St.
2 months ago
Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
Simply Wall St.
2 months ago
Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Motley Fool
2 months ago
3 Mistakes That Can Get Your Costco Membership Canceled
Compare MGX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGX METAGENOMI INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.